Skip to main content
HealthReportedMediumDeveloping
4.8

FDA renews leadership search; lung cancer drug rejected by agency

The FDA is again seeking a new commissioner, marking continued leadership instability at the agency. Separately, the agency rejected a closely tracked lung cancer drug, a setback for the sponsor. The rejection's specific drug and rationale are not detailed in the source.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

STAT Newsabout 7 hours agoUS, CNengCredibility 19%View source

Score Breakdown

Mosaic Score4.8
Model confidence0.5
Significance0.5
Source credibility0.2

Intelligence Tags

Entities

United StatescountryChinacountry
Source

Related signals

8 found